Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Diarrhea-predominant irritable bowel syndrome treatment options eluxadoline, rifaximin, and alosetron: analysis of the FDA adverse event reporting system (FAERS) database
PaperCitations, authors & open-access status
Diarrhea-predominant irritable bowel syndrome treatment options eluxadoline, rifaximin, and alosetron: analysis of the FDA adverse event reporting system (FAERS) database is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1 citations, 2025 year and closed oa status.
1
Citations
2025
Year
closed
OA Status